BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 22672778)

  • 1. Predicting later-life outcomes of early-life exposures.
    Boekelheide K; Blumberg B; Chapin RE; Cote I; Graziano JH; Janesick A; Lane R; Lillycrop K; Myatt L; States JC; Thayer KA; Waalkes MP; Rogers JM
    Environ Health Perspect; 2012 Oct; 120(10):1353-61. PubMed ID: 22672778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asking the right questions: how early-life exposures influence later development of disease.
    Barrett JR
    Environ Health Perspect; 2012 Oct; 120(10):a403. PubMed ID: 23026485
    [No Abstract]   [Full Text] [Related]  

  • 3. The die is cast: arsenic exposure in early life and disease susceptibility.
    Thomas DJ
    Chem Res Toxicol; 2013 Dec; 26(12):1778-81. PubMed ID: 24191665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In utero and early life arsenic exposure in relation to long-term health and disease.
    Farzan SF; Karagas MR; Chen Y
    Toxicol Appl Pharmacol; 2013 Oct; 272(2):384-90. PubMed ID: 23859881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide DNA methylation at birth in relation to in utero arsenic exposure and the associated health in later life.
    Kaushal A; Zhang H; Karmaus WJJ; Everson TM; Marsit CJ; Karagas MR; Tsai SF; Wen HJ; Wang SL
    Environ Health; 2017 May; 16(1):50. PubMed ID: 28558807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early-Life Arsenic Exposure, Nutritional Status, and Adult Diabetes Risk.
    Navas-Acien A; Spratlen MJ; Abuawad A; LoIacono NJ; Bozack AK; Gamble MV
    Curr Diab Rep; 2019 Nov; 19(12):147. PubMed ID: 31758285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of prenatal arsenic exposure on chronic adult diseases.
    Young JL; Cai L; States JC
    Syst Biol Reprod Med; 2018 Dec; 64(6):469-483. PubMed ID: 29873257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of maternal diabetes on epigenetic modifications leading to diseases in the offspring.
    Vrachnis N; Antonakopoulos N; Iliodromiti Z; Dafopoulos K; Siristatidis C; Pappa KI; Deligeoroglou E; Vitoratos N
    Exp Diabetes Res; 2012; 2012():538474. PubMed ID: 23227034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term health consequences of prenatal arsenic exposure: links to the genome and the epigenome.
    Bailey K; Fry RC
    Rev Environ Health; 2014; 29(1-2):9-12. PubMed ID: 24552957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intergenerational programming of metabolic disease: evidence from human populations and experimental animal models.
    Patti ME
    Cell Mol Life Sci; 2013 May; 70(9):1597-608. PubMed ID: 23435955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetics and life-long consequences of an adverse nutritional and diabetic intrauterine environment.
    El Hajj N; Schneider E; Lehnen H; Haaf T
    Reproduction; 2014 Dec; 148(6):R111-20. PubMed ID: 25187623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor Early Growth and Age-Associated Disease.
    Tarry-Adkins JL; Ozanne SE
    Subcell Biochem; 2019; 91():1-19. PubMed ID: 30888647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of early life programming: current knowledge and future directions.
    Tarry-Adkins JL; Ozanne SE
    Am J Clin Nutr; 2011 Dec; 94(6 Suppl):1765S-1771S. PubMed ID: 21543536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Health Effects and Underlying Biological Mechanisms of Developmental Exposure to Arsenic.
    Smeester L; Fry RC
    Curr Environ Health Rep; 2018 Mar; 5(1):134-144. PubMed ID: 29411302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developmental origins of type 2 diabetes: a perspective from China.
    Ma RCW; Tsoi KY; Tam WH; Wong CKC
    Eur J Clin Nutr; 2017 Jul; 71(7):870-880. PubMed ID: 28378847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic basis for fetal origins of age-related disease.
    Thompson RF; Einstein FH
    J Womens Health (Larchmt); 2010 Mar; 19(3):581-7. PubMed ID: 20136551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrauterine programming of obesity and type 2 diabetes.
    Fernandez-Twinn DS; Hjort L; Novakovic B; Ozanne SE; Saffery R
    Diabetologia; 2019 Oct; 62(10):1789-1801. PubMed ID: 31451874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of nutrition during early life on the epigenetic regulation of transcription and implications for human diseases.
    Lillycrop KA; Burdge GC
    J Nutrigenet Nutrigenomics; 2011; 4(5):248-60. PubMed ID: 22353662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In utero arsenic exposure in mice and early life susceptibility to cancer.
    Garry MR; Santamaria AB; Williams AL; DeSesso JM
    Regul Toxicol Pharmacol; 2015 Oct; 73(1):378-90. PubMed ID: 26239692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetics and DOHaD: from basics to birth and beyond.
    Bianco-Miotto T; Craig JM; Gasser YP; van Dijk SJ; Ozanne SE
    J Dev Orig Health Dis; 2017 Oct; 8(5):513-519. PubMed ID: 28889823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.